Cargando…
Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone
Successful management of breast cancer in the metastatic setting is often confounded by resistance to chemotherapeutics, in particular anthracyclines and taxanes. The limited number of effective treatment options for patients with more aggressive biological subtypes, such as triple-negative metastat...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356906/ https://www.ncbi.nlm.nih.gov/pubmed/22645612 http://dx.doi.org/10.1155/2012/703858 |